| related words |
| laboratory |
| diagnostic |
| ingredient |
| compound |
| distributing |
| phase |
| advanced |
| division |
| administration |
| demonstrate |
| discontinue |
| performed |
| cancer |
| stringent |
| scale |
| monitoring |
| manufactured |
| therapy |
| unproven |
| marketed |
|
| related documents |
| 1260990--3/2/2006--GTX_INC_/DE/ |
| 886744--2/27/2009--GERON_CORP |
| 886744--2/28/2008--GERON_CORP |
| 886744--3/16/2007--GERON_CORP |
| 1260990--3/15/2010--GTX_INC_/DE/ |
| 1260990--3/3/2009--GTX_INC_/DE/ |
| 901219--2/28/2007--HUMAN_GENOME_SCIENCES_INC |
| 1159036--3/9/2007--HALOZYME_THERAPEUTICS_INC |
| 1260990--3/9/2007--GTX_INC_/DE/ |
| 740670--3/31/2010--MICHAELS_STORES_INC |
| 1031296--2/28/2007--OHIO_EDISON_CO |
| 1367644--3/27/2007--Emergent_BioSolutions_Inc. |
| 853695--3/28/2007--DIGITAL_RECORDERS_INC |
| 1107332--3/14/2007--DENDREON_CORP |
| 1099590--2/26/2010--MERCADOLIBRE_INC |
| 20947--2/28/2007--OHIO_EDISON_CO |
| 716133--3/1/2007--CINCINNATI_BELL_INC |
| 865231--3/1/2007--CELL_GENESYS_INC |
| 924642--3/15/2007--APPLIED_DIGITAL_SOLUTIONS_INC |
| 1128495--3/15/2007--ANADYS_PHARMACEUTICALS_INC |
|
| related topics |
| {product, candidate, development} |
| {product, liability, claim} |
| {cost, regulation, environmental} |
| {cost, operation, labor} |
| {system, service, information} |
| {financial, litigation, operation} |
| {product, market, service} |
| {regulation, government, change} |
| {acquisition, growth, future} |
| {competitive, industry, competition} |
| {gas, price, oil} |
| {property, intellectual, protect} |
| {capital, credit, financial} |
| {cost, contract, operation} |
| {operation, natural, condition} |
| {customer, product, revenue} |
| {interest, director, officer} |
| {personnel, key, retain} |
| {stock, price, operating} |
| {operation, international, foreign} |
|